Ashley Grossman

Queen Mary University of London — United Kingdom

Medicine · Health Sciences

117h-index54.9kcitations1.1kworks3.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pituitary Gland Disorders and Treatments(476), Adrenal and Paraganglionic Tumors(212), Growth Hormone and Insulin-like Growth Factors(210), Neuroendocrine Tumor Research Advances(191), Adrenal Hormones and Disorders(190)

Publications1.1k total

The Utility of Cabozantinib in the Therapy of Endocrine Tumours
Endocrine Pathology·2025
Adrenal tumour imaging: clinical, molecular, and radiomics perspectives
The Lancet Diabetes & Endocrinology·2025
A novel activating somatic EPAS1 variant in the hypoxia signalling pathway in a patient with paraganglioma and sickle cell disease
Endocrine Abstracts·2025
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents
Nature Reviews Endocrinology·2025Open Access
Endocrine and metabolic consequences of childhood-onset craniopharyngioma during the transition age: A literature review by the TALENT study group
Reviews in Endocrine and Metabolic Disorders·2025· 1 citedOpen Access
Metastatic Pheochromocytoma in a Patient With Li-Fraumeni Syndrome
JCEM Case Reports·2025Open Access
Adrenal causes of endocrine hypertension in childhood or adolescence
Journal of Endocrinological Investigation·2025Open Access
A novel molecular imaging technique using [68Ga]Ga-mDesmo PET-CT for localizing tumors in Cushing’s disease
European Journal of Nuclear Medicine and Molecular Imaging·2025· 3 cited
Upregulation of SSTR2 Expression and Radioligand Binding of [<sup>18</sup>F]SiTATE in Neuroendocrine Tumour Cells with Combined Inhibition of Class I HDACs and LSD1
Neuroendocrinology·2025· 1 citedOpen Access
Pulmonary Fibrosis in a Patient With a Prolactinoma on Dopamine Agonists: Coincidence or Consequence
JCEM Case Reports·2025Open Access
Alpha-particle therapy for neuroendocrine tumors: A focused review
Brain medicine :·2025Open Access
Endocrine and Neuroendocrine Tumours
2025· 20 cited
Metabolically active brown adipose tissue in PPGL: an observational cohort study
Endocrine Related Cancer·2025· 2 citedOpen Access
Non-Hypertensive Effects of Aldosterone
International Journal of Molecular Sciences·2025· 7 citedOpen Access
Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma
The Journal of Clinical Endocrinology & Metabolism·2025· 2 citedOpen Access
177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in metastatic phaeochromocytomas and paragangliomas (mPPGL): a single centre retrospective analysis of experience at an ENETS Centre of Excellence
Endocrine Oncology·2025Open Access
Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
Endocrine Oncology·2025Open Access
68Ga-DOTA-TATE PET/CT improves accuracy and guides management in multiple endocrine neoplasia type 1 (MEN-1) patients with suspected duodeno-pancreatic neuroendocrine tumours
Endocrine Oncology·2025Open Access
Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas
Endocrine Oncology·2025Open Access
The diagnostic value of prolactin adjustment in bilateral inferior petrosal sinus sampling for differentiating Cushing’s disease from the ectopic ACTH syndrome: a systematic review and meta-analysis
Pituitary·2024· 2 cited
page 1 of 55Next →

Frequent Co-authors

Márta Korbonits(12), Gregory Kaltsas(10), John Newell‐Price(9), G. M. Besser(9), John P. Monson(7), Peter Trainer(6), John Wass(6), Blerina Kola(5), Andrea Giustina(4), Шломо Мелмед(4), Philippe Chanson(4), Rodney H. Reznek(4), Paul J. Jenkins(4), James W. Findling(3), Lynnette K. Nieman(3), M. L. Vance(3), Marco Boscaro(3), Andrea Rockall(3), Edward R. Laws(3), Ken K. Y. Ho(3)